BVF Partners L P/il, Director at Kymera Therapeutics, Inc. (KYMR), sold 1,630,658 shares at $106.50 ($173.7M) on 2026-06-26, disclosed to the SEC on 2026-06-26.
Open-market sale of $173.7M KYMR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.50 | 51,858 | $5.5M | 3.2% |
| 2 | $106.50 | 113,289 | $12.1M | 6.9% |
| 3 | $106.50 | 627,597 | $66.8M | 38.5% |
| 4 | $106.50 | 837,914 | $89.2M | 51.4% |
| Total | $106.50 avg | 1,630,658 | $173.7M | 100% |
| Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |
| XOMA | BUY | 2020-03-17 | $2.4M | — | Filing → |